Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mine Harada

Showing results (91-100 of 251) with videos related to

Pageof 26
Sort By:
The Journal of Biological Chemistry|December 31, 2003
SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signalingAkiko Kimura, Ichiko Kinjyo, Yumiko Matsumura, et al.
Internal Medicine (Tokyo, Japan)|October 17, 2007
Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behçet's disease by up-front cord blood transplantationAtsushi Nonami, Katsuto Takenaka, Chinatsu Sumida, et al.
Modern Rheumatology|December 5, 2006
MPO-ANCA-positive Wegener's granulomatosis presenting with hypertrophic cranial pachymeningitis: case report and review of the literatureMitsuteru Akahoshi, Goichi Yoshimoto, Hitoshi Nakashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell lineHiroyuki Kohara, Masahiro Tabata, Katsuyuki Kiura, et al.
Anticancer Research|August 10, 2002
Gastric perforation due to metastasis from adenocarcinoma of the lungNoriyuki Suzaki, Akio Hiraki, Hiroshi Ueoka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Antilung cancer effect of WT1-specific cytotoxic T lymphocytesMasanori Makita, Akio Hiraki, Taichi Azuma, et al.
Oncology Reports|August 4, 2005
Synergistic interaction between oxaliplatin and SN-38 in human gastric cancer cell lines in vitroRisa Tanaka, Hiroshi Ariyama, Baoli Qin, et al.
Acta Medica Okayama|January 18, 2003
Daily low-dose cisplatin and concurrent thoracic irradiation for poor-risk patients with unresectable non-small-cell lung cancerIchiro Takata, Hiroshi Ueoka, Katsuyuki Kiura, et al.
Cancer|October 5, 2002
Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemiaAkio Hiraki, Hiroshi Ueoka, Akihiro Bessho, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factorsTsuyoshi Kodani, Hiroshi Ueoka, Katsuyuki Kiura, et al.
Pageof 26

Showing results (91-100 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Biological Chemistry|December 31, 2003
SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signalingAkiko Kimura, Ichiko Kinjyo, Yumiko Matsumura, et al.
Internal Medicine (Tokyo, Japan)|October 17, 2007
Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behçet's disease by up-front cord blood transplantationAtsushi Nonami, Katsuto Takenaka, Chinatsu Sumida, et al.
Modern Rheumatology|December 5, 2006
MPO-ANCA-positive Wegener's granulomatosis presenting with hypertrophic cranial pachymeningitis: case report and review of the literatureMitsuteru Akahoshi, Goichi Yoshimoto, Hitoshi Nakashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell lineHiroyuki Kohara, Masahiro Tabata, Katsuyuki Kiura, et al.
Anticancer Research|August 10, 2002
Gastric perforation due to metastasis from adenocarcinoma of the lungNoriyuki Suzaki, Akio Hiraki, Hiroshi Ueoka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Antilung cancer effect of WT1-specific cytotoxic T lymphocytesMasanori Makita, Akio Hiraki, Taichi Azuma, et al.
Oncology Reports|August 4, 2005
Synergistic interaction between oxaliplatin and SN-38 in human gastric cancer cell lines in vitroRisa Tanaka, Hiroshi Ariyama, Baoli Qin, et al.
Acta Medica Okayama|January 18, 2003
Daily low-dose cisplatin and concurrent thoracic irradiation for poor-risk patients with unresectable non-small-cell lung cancerIchiro Takata, Hiroshi Ueoka, Katsuyuki Kiura, et al.
Cancer|October 5, 2002
Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemiaAkio Hiraki, Hiroshi Ueoka, Akihiro Bessho, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factorsTsuyoshi Kodani, Hiroshi Ueoka, Katsuyuki Kiura, et al.
Pageof 26